M. Dahl (Køge, Denmark), F. Ricciardolo (Orbassano (TO), Italy)
Bone Morphogenic Proteins and their antagonists in the lower airways of stable COPD patients A. Di Stefano (Veruno (NO), Italy), I. Gnemmi (Veruno (NO), Italy), F. Dossena (Veruno (NO), Italy), U. Rosani (Padova, Italy), P. Brun (Padova, Italy), A. Leonardi (Padova, Italy), B. Balbi (Padova, Italy), F. Nucera (Messina, Italy), V. Carriero (Torino, Italy), F. Bertolini (Torino, Italy), S. D'Anna (Telese, Italy), M. Maniscalco (Telese, Italy), I. Adcock (London, United Kingdom), G. Caramori (Messina, Italy), F. Ricciardolo (Torino, Italy)
| |
What is walking? a systematic review and meta-ethnography L. Delgado Ortiz (Barcelona, Spain), A. Polhemus (Zurich, Switzerland), A. Keogh (Dublin , Ireland), N. Sutton (Newcastle, United Kingdom), W. Remmele (Newcastle, United Kingdom), C. Hansen (Kiel, Germany), F. Kluge (Erlangen, Germany), B. Sharrack (Sheffield, United Kingdom), C. Becker (Stuttgart , Germany), T. Troosters (Leuven, Belgium), W. Maetzler (Kiel, Germany), L. Rochester (Newcastle, United Kingdom), A. Frei (Zurich, Switzerland), M. Puhan (Zurich, Switzerland), J. Garcia-Aymerich (Barcelona, Spain)
| |
Effects of breathing-based meditation on dyspnea in COPD, a single-case study T. Lin (Fresno, United States), S. Shune (Eugene, United States)
| |
Survival of COPD patients according to the new phenotypes defined in Spanish COPD Guidelines 2021 Z. Ji (Madrid, Spain), J. Hernández Vázquez (Madrid, Spain), I. Domínguez Zabaleta (Madrid, Spain), I. Ali García (Madrid, Spain), C. Matesanz Ruiz (Madrid, Spain), W. Girón Matute (Madrid, Spain), D. Martos Ruiz (Madrid, Spain), P. García Valentín (Madrid, Spain), M. Esteban Yagüe (Madrid, Spain), J. De Miguel Díez (Madrid, Spain)
| |
Thrombophilia as a factor in increasing inflammation in COPD E. Abduganieva (Tashkent, Uzbekistan)
| |
The BLF Early COPD Consortium: Respiratory Oscillometry Detects Abnormalities before Lung Function Testing A. Ritchie (London, United Kingdom), G. Donaldson (London, United Kingdom), O. Usmani (London, United Kingdom), A. Bikov (Manchester, United Kingdom), L. Alves-Moreira (London, United Kingdom), J. Vestbo (Manchester, United Kingdom), P. Calverley (Liverpool, United Kingdom), J. Wedzicha (London, United Kingdom)
| |
Advanced lung function targeting small airway dysfunction (SAD) improves differentiation of mild COPD and smokers at risk from healthy controls – CAPTO-COPD F. Trinkmann (Heidelberg, Germany), M. Abdo (Grosshansdorf, Germany), A. Kirsten (Grosshansdorf, Germany), K. Rabe (Grosshansdorf, Germany), F. Herth (Heidelberg, Germany), H. Watz (Grosshansdorf, Germany), M. Abdo (Grosshansdorf, Germany)
| |
Health-related quality of life (HRQL) is associated with small airway dysfunction (SAD) in mild COPD and smokers at risk – cross-sectional baseline data from CAPTO-COPD F. Trinkmann (Heidelberg, Germany), A. Kirsten (Grosshansdorf, Germany), M. Abdo (Grosshansdorf, Germany), K. Rabe (Grosshansdorf, Germany), F. Herth (Heidelberg, Germany), H. Watz (Grosshansdorf, Germany), M. Abdo (Grosshansdorf, Germany)
| |
TRONARTO post hoc analysis: factors affecting peak inspiratory flow (PIF) variability D. Mahler (Hanover, United States), H. Watz (Grosshansdorf, Germany), R. Emerson-Stadler (Ingelheim, Germany), J. Ritz (Somerset, United States), A. Shaikh (Ridgefield, United States), M. Drummond (Chapel Hill, United States)
| |
Sarcopenia is associated with cardiovascular risk in patients with COPD, independent of adiposity J. Jung (Seoul, Republic of Korea), A. Leem (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), K. Chung (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), Y. Kang (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea)
| |
Correlations between volumetric capnography and automated quantitative computed tomography analysis in patients with severe COPD O. Diniz (Campinas, Brazil), M. Pereira (Campinas, Brazil), S. Da Silva (Campinas, Brazil), M. Santos (Ribeirão Preto, Brazil), I. Paschoal (Campinas, Brazil), M. Moreira (Campinas, Brazil)
| |
Principal component analysis of flow-volume curves in COPDGene to link spirometry with phenotypes of COPD K. Verstraete (Leuven, Belgium), N. Das (Leuven, Belgium), I. Gyselinck (Leuven, Belgium), M. Topalovic (Leuven, Belgium), T. Troosters (Leuven, Belgium), M. De Vos (Leuven, Belgium), W. Janssens (Leuven, Belgium)
| |
PROM and PREM preferences in COPD-patients I. Gyselinck (Leuven, Belgium), K. Vermeersch (Leuven, Belgium), H. Pott (Marburg, Germany), S. Ramakrishnan (Oxford, United Kingdom), A. Halner (Oxford, United Kingdom), P. Collis (Birmingham, United Kingdom), C. Coleman (Sheffield, United Kingdom), H. Watz (Grosshansdorf, Germany), F. Dobbels (Leuven, Belgium), F. Franssen (Maastricht, Netherlands), T. Greulich (Marburg, Germany), P. Burgel (Paris, France), M. Bafadhel (Oxford, United Kingdom), W. Janssens (Leuven, Belgium)
| |
Rapid FEV1/FVC decline is a risk factor for chronic obstructive pulmonry disease and mortality in general population K. Choi (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), T. Park (Seoul, Republic of Korea), E. Heo (Seoul, Republic of Korea), D. Kim (Seoul, Republic of Korea), H. Lee (Seoul, Republic of Korea)
| |
Probabilistic modeling of COPD imaging characteristics for disease severity prediction S. Dias Almeida (Heidelberg, Germany), T. Norajitra (Heidelberg, Germany), C. Lueth (Heidelberg, Germany), T. Wald (Heidelberg, Germany), T. Kopytova (Heidelberg, Germany), M. Nolden (Heidelberg, Germany), P. F. Jaeger (Heidelberg, Germany), C. Peter Heussel (Heidelberg, Germany), J. Biederer (Heidelberg, Germany), H. Kauczor (Heidelberg, Germany), O. Weinheimer (Heidelberg, Germany), K. Maier-Hein (Heidelberg, Germany)
| |
Analysis of brain functional connectivity in COPD patients with functional brain MRI Y. Yeo (Guri-si, Republic of Korea), J. Rhu (Seoul, Republic of Korea), H. Jo (Seoul, Republic of Korea), S. Jang (Guri-si, Republic of Korea), J. Choi (Guri-si, Republic of Korea), D. Park (Guri-si, Republic of Korea), T. Kim (Guri-si, Republic of Korea)
| |
FEV1 decline is accelerated in only a minority of patients with COPD: a factorial analysis of longitudinal data P. Burgel (Paris, France), T. Perez (Lille, France), G. Deslée (Reims, France), M. Zysman (Bordeaux, France), O. Le Rouzic (Lille, France), P. Chanez (Marseille, France), G. Jébrak (Paris, France), I. Court-Fortune (Saint Etienne, France), G. Brinchault (Rennes, France), P. Nesme-Meyer (Lyon, France), A. Guillaumot (Nancy, France), B. Ribeiro-Baptista (Créteil, France), E. Ouaalaya (Paris, France), J. Paillasseur (Paris, France), N. Roche (Paris, France)
| |
129Xe-MRI and lung function to phenotype ventilation heterogeneity in asthma and/or COPD L. Smith (Sheffield, United Kingdom), H. Marshall (Sheffield, United Kingdom), D. Jakymelen (Sheffield, United Kingdom), A. Biancardi (Sheffield, United Kingdom), G. Collier (Sheffield, United Kingdom), H. Chan (Sheffield, United Kingdom), P. Hughes (Sheffield, United Kingdom), M. Brook (Sheffield, United Kingdom), J. Astley (Sheffield, United Kingdom), R. Munro (Sheffield, United Kingdom), S. Rajaram (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom), D. Capener (Sheffield, United Kingdom), J. Bray (Sheffield, United Kingdom), J. Ball (Sheffield, United Kingdom), O. Rodgers (Sheffield, United Kingdom), I. Smith (Sheffield, United Kingdom), B. Tahir (Sheffield, United Kingdom), M. Rao (Sheffield, United Kingdom), G. Norquay (Sheffield, United Kingdom), N. Weatherley (Sheffield, United Kingdom), L. Armstrong (Sheffield, United Kingdom), L. Hardaker (York, United Kingdom), T. Fihn-Wikander (Gothenburg, Sweden), R. Hughes (Cambridge, United Kingdom), J. Wild (Sheffield, United Kingdom)
| |
Prediction of V’O2max in advanced COPD patients using the Oxygen Uptake Efficiency Slope M. Maenen (Heerlen, Netherlands), L. Van Den Broek (Heerlen, Netherlands), L. Somers (Heerlen, Netherlands), A. Hanneman (Heerlen, Netherlands), J. Van Den Aardweg (Amsterdam, Netherlands), R. Baba (Kasugai city, Japan), M. De Kruif (Heerlen, Netherlands)
| |